Clin2
NCT06995625Possibly a fitRecruiting

Stem cell particles for recent stroke recovery

Acute Ischemic Stroke AIS

Part of Brain & nervous system, Heart & circulation clinical trials.

This trial tests whether stem cell-derived extracellular vesicles can help people recover after a moderate to severe stroke. You may join if you had a stroke in the last 5 days and still have arm or leg weakness, even after standard treatments like clot-busting drugs or clot removal.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
18 people
Ages
19 years and older
Study type
Interventional

Who can take part

  • You are 19 years or older
  • Your stroke started within the past 5 days
  • You have moderate to severe stroke symptoms, including weakness in an arm or leg
  • You have not had a prior disability that affected your daily life before the stroke
  • You are able to have an MRI scan (no pacemaker or metal implants that would prevent it)
  • You are not pregnant, breastfeeding, or planning to become pregnant during the study

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07084012Recruiting· Phase 2
Stem cell treatment for recent stroke

This trial tests whether a single infusion of umbilical cord stem cells can help people recover from a recent ischemic stroke (stroke caused by a clot). It is for patients who have had their stroke within the last 72 hours and have moderate to severe symptoms.

Beijing, Beijing Municipality
NCT06129175Recruiting· Phase 2/Phase 3
Stem cells for recent moderate to severe stroke

This trial is testing a new treatment using stem cells from donated umbilical cord tissue to help people recover from a recent moderate to severe stroke. It is for patients who cannot receive standard clot-busting treatments.

Cheras, Kuala Lumpur
NCT06612710Recruiting· Phase 1
A study of NouvSoma001 for recent stroke recovery

This trial tests a new treatment called NouvSoma001 for people who have had an ischemic stroke within the last week. It aims to see if the treatment is safe and helps improve muscle strength and overall recovery.

Wuhan, Hubei
NCT07398612Not yet recruiting· Phase 1/Phase 2
Stem cell exosomes for acute ischemic stroke

This clinical trial is testing a treatment made from stem cell exosomes — tiny particles that help cells communicate — given through an IV to people who have had a recent ischemic stroke caused by a blood clot. The study aims to see if it's safe and can help recovery when given within the first few days after a stroke.

NCT06518902Not yet recruiting· Phase 1
Stem cell infusion for recent stroke recovery

This trial tests whether umbilical cord stem cells given within a month after a stroke can help patients recover. It is for people with a moderate to moderately severe stroke affecting the front part of the brain.

NCT07143786Not yet recruiting· Phase 1/Phase 2
Exosomes for acute ischemic stroke treatment

This trial tests whether exosomes from human stem cells can help people recover after a stroke in the front part of the brain. You must start treatment within one week of the stroke, have a certain level of disability, and be generally healthy otherwise.

Hear when a new Acute Ischemic Stroke AIS trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.